Skip to main content
. 2014 Sep 9;48(9):752–764. doi: 10.1097/MCG.0000000000000180

FIGURE 4.

FIGURE 4

Response in patients treated with NASHA Dx (n=136) compared with sham treatment (n=70). A, The mean change from baseline in number of incontinence-free days over 2 weeks. B, The mean relative percentage change in FIQOL scores by category. FIQOL indicates Fecal Incontinence Quality of Life; NASHA Dx, dextranomer microspheres in non-animal stabilized hyaluronic acid. Adapted from Graf et al.109